Hemodialysis today has evolved
|
|
- Milton Ferguson
- 5 years ago
- Views:
Transcription
1 Lessons in Dialysis, Dialyzers, and Dialysate Robert Hootkins, MD, PhD The author is Chief of Nephrology and Hypertension at The Austin Diagnostic Clinic, Austin, Texas. He is also a member of D&T s editorial advisory board. Hemodialysis today has evolved into a highly technical treatment in which knowledge of the physics and chemistry of the dialysis treatment system as well as knowledge of individual patient s pathology allows for a better understanding of how the treatment is best performed and individually modified. The treatment prescription is a set of specific treatment parameters that includes the treatment duration and frequency, the choice of dialyzer, and the specifics of the dialysate composition. It is imperative that the nephrologist understand how to deliver the most optimal treatment that is additionally the most cost effective. Dialysis In short, hemodialysis is the process by which a patient s blood can be chemically modified by driving it through a device (dialyzer) that allows for the removal of substances (blood solutes) as well as the gain of substances (dialysate solutes) with the additional option of the simultaneous removal of plasma water. It has evolved for almost a century but remains dependent on the chemical properties of a semipermeable membrane that is selective to the movement of solute and resistive to the movement of solvent. The primary purpose of dialysis is to eliminate uremic poisons in patients with end-stage renal disease and to modify serum electrolytes so as to mimic the appropriate serum composition of healthy individuals. Dialyzers and Solute Clearance A dialyzer can be classified based on properties of the chemical composition of its membrane or based on its properties of solute removal (most commonly urea removal) and solvent permeability (most commonly water, termed hydraulic permeability) under specific operating conditions (blood flow rate [QB in ml/min] and dialysate flow rate [QD in ml/min]). Some dialyzers are more efficient at solute removal and are termed high-efficiency, whereas other dialyzers have lesser resistance to water movement and are termed high-flux. Dialyzer membrane properties have been recently reviewed. 1 Using a simple model of hemodialysis operating conditions, the removal of a solute like urea can be approximated by an equation derived by Michaels 2 in which the removal of a solute K from blood can be expressed by the clearance equation: in which the dialyzer s ability to remove a solute K is proportional to the product of the mass transfer coefficient of that dialyzer s membrane (Ko) and the membrane surface area (A). KoA is specific to a particular solute (such as urea) and is independent of QB and QD (assumption of the model). The KoA of a particular dialyzer is provided by the manufacturer, is determined in vitro in aqueous solutions, and usually overestimates by about 20% when compared with in vivo blood-based solutions containing proteins and red blood cells. It is difficult to fully appreciate the relationships among KoA, QB, and QD. Figure 1 presents these relationships graphically, depicting urea clearance K as a function of QB for a dialyzer KoA of 1,000 and three separate QDs of 1,000, 500, and 400 ml/min (from the top curve down). At lower QBs, the clearance (K) is linear with QD, but as QB increases closer to QD, there is a diminishing benefit of increasing QB further (as QD becomes clearance limiting). Many insights can be obtained by an analysis of the clearance equation. Table I illustrates the effects on the overall clearance of urea of changing a number of parameters. The first observation is that the overall clearance is simply determined by the lowest of the three parameters KoA, QB, and QD. Most high-efficiency, high-flux dialyzers have a KoA for urea of 1,000-2,000. Since QDs are typically in the range of ml/min. Dialyzer membrane properties have it is the lowest parameter, QB (typically in the range of ml/min) that determines the overall clearance K. In fact, the more general observation is that clearance becomes limited as QB approaches either QD or KoA. Additionally, if the magnitude of both QD and KoA are close to QB, QB is even further diminished. There are practical ramifications of these observations. One lesson is that in this current era of bundling and small financial margins, it makes sense not to spend resources on dialyzers that have excessively high KoAs in that their benefit will be minimized by the QB, which is, in turn, limited by access flow and needle resistance limitations. In general, KoAs in excess of 1,000 are of marginal benefit. An additional lesson is that with daily hemodialysis methodologies that have reduced QDs of 150 ml/min (for example, NxStage) or continuous veno-venous hemodialysis (CVVHD) techniques with QDs of ml/min, there is no reason to employ higher QBs or to use large dialyzers, as K will be limited by QD. Another example of an even greater waste of financial resources is the use of two dialyzers simultaneously, combined either in-parallel (Figure 2A) or in-series (Figure 2B) to effectively increase KoA. Table II illustrates the overall effect on clearance by use of these configurations. Although a theoretical added clearance of about 14-15% can be achieved, the total dialysis treatment dose can often be obtained more cost effectively by simply 392 Dialysis & Transplantation September 2011 DOI: /dat.20609
2 for a specific dialyzer (Fresenius F80) results in the determination of of 0.9 and a KoA of 20. Graphing the clearance (here defined as D ) of vancomycin as a function of QB and QF (Figure 3) demonstrates that it is removed more effectively with lower QBs and higher QFs. For larger solutes cleared by convection, the greater the time of the dialysis membrane exposure (slower QB) and the greater the pressure gradient across the dialyzer membrane (higher QF), the greater the clearance. The opposite of this is true as well. For example, to minimize vancomycin clearance, faster QBs and smaller QFs will clear less of the antibiotic for a given dialysis prescription. FIGURE 1. Dialysis clearance equation. K versus QB for QD = 1,000, 500, 400 [KoA = 1,000]. extending the dialysis treatment time using a single dialyzer by an additional minutes with a minimal added cost of dialysate consumption! To employ the other configurations, additional connectors must also be purchased, increasing the costs associated with the treatment. Additionally, these configurations also result in greater dialysis disequilibrium (faster rate of solute removal, which is proportional to K/V); depending on the methodology of the urea kinetic modeling utilized, this can lead to greater overestimation of solute removal and a false sense of security that enough dialysis is being performed. It is important to know that the clearance equation only applies under a set of ideal circumstances including the absence of convection (ultrafiltration). For the removal of urea, this is a fair approximation since it is primarily eliminated by diffusion, not convection, and Fick s law TABLE I. Dialysis clearance equation. applies. In most dialysis treatments, however, the ultrafiltration rate can be significant. A more general equation can be derived that includes the effects of both diffusion and ultrafiltration but is beyond the scope of this article. 3 Fortunately, however, in the limit of solutes that are large enough to be cleared predominantly by ultrafiltration and not diffusion (for example, vancomycin), the more general equation 3 simplifies to: K = (1 ) QF + KoA. The sigma ( ) relates to the permeability of the dialysis membrane to a particular solute. This equation is the equation of a straight line, and if one experimentally measures the clearance of a molecule as a function of ultrafiltration rate, QF in ml/min, the and KoA can be determined from the slope (1 )and the intercept (KoA). 3 Doing this for the clearance of vancomycin (molecular weight of 1,486) KoA QB QD Clearance % Increase 1, , , % 1,000 1, % 10, % Additional Degrading Factors That Reduce the Actual Clearance of Substances As a result of dialysis being performed in a in-parallel fashion, there is the generation of both an access recirculation (AR) and a cardiopulmonary recirculation (CPR). The dialyzer operating in-parallel with the peripheral access results in AR, and the peripheral access operating in-parallel with the systemic venous circulation results in CPR (Figure 4). AR and CPR effectively prevent the dialyzer from actually receiving blood with systemic concentrations of solute; instead, a diluted sampling of systemic venous blood with solute cleared blood is received (Figure 5). (The extraction efficiency of a dialyzer is proportional to the incident concentration of the solute to be removed). The mathematics of these effects has been worked out by Schneditz et al. 4 As a consequence, the actual removal of solute is not only based on the dialysis treatment prescription but is also dependent on patient specific parameters that include cardiac output and venous flow through the peripheral access. Another barrier to our effectively eliminating urea from a patient s body results from the fact that the storage of urea occurs primarily in the skeletal muscle and its removal may depend on the vascular communication of this compartment with the central venous system. This provides one theory of why exercise during dialysis improves the September 2011 Dialysis & Transplantation 393
3 FIGURE 3. K vs QB [QF = ] [ = 0.9, K0A = 20, QD = 500]. From reference 3. anemia, a cardiomyopathy, and poorly functioning access flow. Ultimately, patient B receives 30% less dialysis in spite of having the same identical treatment prescription. The lesson here is that the actual delivered amount of dialysis can be significantly less than the theoretically prescribed dialysis. Flow recirculations (AR and CPR) and a patient s individual physiology (urea trapping in skeletal muscle and cardiac output) and access health result in a delivered clearance dependent on factors out of our prescriptive control. Careful consideration of a patient s cardiac status and access health may indicate a need for additional clearance beyond that predicted by an a simple analysis of his or her urea kinetic modeling. Dialysate FIGURE 2. A) Operational confi guration of 2 dialyzers placed in-parallel; B) Operational confi guration of 2 dialyzers placed in-series. Reprinted from AJKD (reference 7), copyright 2003, with permission from Elsevier. quality of urea removal: it allows for greater vascular flow (improved communication) with the skeletal compartment and a subsequent higher central venous concentration of urea. Table III illustrates a comparison between two patients with an identical extracorporeal dialysis treatment prescription but different cardiac output and access flows. Patient A is relatively healthy with a normal cardiac output and no significant access pathology. Patient B has mild Dialysis machines employ a proportioning system that mixes an acid concentrate with a bicarbonate concentrate and purified water. This allows for the generation of a dialysate with a physiologic ph and minimizes the possibility of forming a precipitate between bicarbonate containing alkaline solutions and calcium. The acid concentrate contains dextrose and is the source of electrolytes including potassium, calcium, magnesium, and acetic (or citric) acid. The bicarbonate concentrate may contain sodium chloride as well as sodium bicarbonate (36.83 ) or may contain only sodium bicarbonate (35 /45 ). The nomenclature of the commonly used Fresenius 45x system is derived from the fact that the proportioning system mixes 1 part acid concentrate to 1.72 parts bicarbonate concentrate to parts water, which adds up to 45 parts. It is important to understand that modifying the prescription for sodium or bicarbonate 394 Dialysis & Transplantation September 2011
4 TABLE II. Effect on clearance of using two dialyzers. Operating conditions: KoA = 1,000 QB = 400, QD = 800 Single dialyzer: K = 333 ml/min Two dialyzers in series: K = 380 ml/min (+14%) Two dialyzers in parallel: K = 383 ml/min (+15%) in real time during rounding will alter all electrolyte concentrations of the dialysate solution. Most current equipment will show the effects of changing the dialysate proportioning in real time. It is also of importance that the total buffer in this system include bicarbonate as well as acetate (or citrate), which can add an additional meq/l buffer. If one prescribes a dialysate bicarbonate delivery of 35 meq/l, the total delivered buffer will be the sum of the bicarbonate and the acetate (or citrate) from the acid concentrate (which is metabolized to bicarbonate in the liver). Therefore, the total delivered base (TDB) to a patient has to include consideration of both bicarbonate and acetate (or citrate) buffers. Consequently, on longer dialysis treatments using high bicarbonate concentrations (40 meq/l), we can induce a chronic metabolic alkalosis, which can have adverse effects on patient mortality (based on mortality data obtained by several large dialysis providers). FIGURE 4. Origin of AR and CPR as depicted by parallel blood fl ows from dialyzer to access, and access to the systemic circulation. FIGURE 5. Reduced effi ciency from AR adn CPR results from blood effectively cleared of urea nitrogen by dialysis being mixed with blood with high urea nitrogen from its primary source (skeletal muscle tissue). This mixing reduces the concentration of urea nitrogen returning back to the central venous compartment and leads to reduced urea nitrogen concentration in the blood incident to the dialyzer. Specifi c Dialysate Electrolytes: Sodium and Calcium High dialysate sodium concentrations can lead to sodium loading, increased thirst, and subsequent high weight gains and hypertension. A chronic state of volume overload and hypertension ultimately leads to left ventricular hypertrophy and cardiac dysfunction. Sodium is removed from the patient both by ultrafiltration (for patients with large weight gains) and by diffusion. Consequently, the total fluid removed as well as the sodium gradient between the patient and the dialysate at the initiation of the treatment are both critical factors. It has been suggested that individualizing the dialysis sodium concentration to be slightly less than a patient s historic sodium concentration may be the best way to prevent sodium loading. 5 Much controversy exists over the optimal calcium concentrations in dialysate. A concern exists that calcium loading may be harmful to patients and that many hemodialysis patients are constantly exposed to a state of positive calcium balance between the oral ingestion of calcium in foods and binders as well as from a positive calcium influx from the dialysate. This positive calcium balance may contribute to calcium deposition in arterial vessels and heart September 2011 Dialysis & Transplantation 395
5 TABLE III. Comparison between two patients with the same dialysis but different cardiac output and access fl ows. Parameter Patient A Patient B Hct 35% 30% CO 10 L/min 6 L/min Access fl ow 1, Access recirculation 1% 15% KoA 1,200 1,200 QB QD QF % Reduction from theoretical K 4% 30% valves. A recent mathematical analysis of this issue by Gotch et al. 6 suggests that dialysate concentrations below 2.5 meq/l may be necessary to limit calcium influx from the dialysate. Is the Dialysate Delivered the Dialysate Prescribed? One assumes that if the hemodialysis machine is set appropriately with the correct concentrates, then the dialysate composition delivered to each dialyzer is exactly as prescribed. Unfortunately, a number of variables can affect the proportioning system, one being the inlet pressure of the dialysis concentrates and water entering into the dialysis machine. Depending on the open or closed loop nature of the distribution system, inlet pressures to the machines can significantly vary even by position within the loop. To promote a more consistent pressure, a gravity feed system is often utilized. Perhaps one of the most significant aspects of the quality assessment of each dialysis facility is to ensure the correct dialysate delivery to each patient s dialyzer by sampling dialysate at the first and last chair of each distribution loop. Most dialysis specialty labs can measure electrolytes on non-blood samples and provide this as a safety check. D&T References 1. Ward RA. Do clinical outcomes in chronic hemodialysis depend on the choice of a dialyzer? Semin Dial. 2011;24: Michaels AS. Operating parameters and performance criteria for hemodialyzers and other membrane-separation devices. Trans Am Soc Artif Intern Organs. 1966;12: Hootkins R, Bourgeois B. The effect of ultrafi l- tration on dialysis: mathematical theory and experimental verifi cation. ASAIO Trans. 1991;37: M Schneditz D, Kaufman A, Polaschegg D,Levin NL, Daugirdas J. Cardiopulmonary recirculation during hemodialysis. Kidney Int. 1992;42: Penne EL, Sergeyeva O. Sodium gradient: a tool to individualize dialysate sodium prescription in chronic hemodialysis patients? Blood Purif. 2011;31: Gotch F, Levin NL, Kotanko P. Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between intake, dose of vitamin d analogs and the dialysate calcium concentration. Blood Purif. 2010;29: Fritz BA, Doss S, McCann LM, Wrone EM. A comparison of dual dialyzers in parallel and series to improve urea clearance in large hemodialysis patients. Am J K Dis. 2003;41: Dialysis & Transplantation September 2011
Implementing therapy-delivery, dose adjustments and fluid balance. Eileen Lischer MA, BSN, RN, CNN University of California San Diego March 6, 2018
Implementing therapy-delivery, dose adjustments and fluid balance. Eileen Lischer MA, BSN, RN, CNN University of California San Diego March 6, 2018 Objectives By the end of this session the learner will
More informationNephrology Dialysis Transplantation
Nephrol Dial Transplant (1996) 11 [Suppl 2]: 75-80 Nephrology Dialysis Transplantation Recirculation and the post-dialysis rebound J. E. Tattersall, P. Chamney, C. Aldridge and R. N. Greenwood Lister Hospital,
More informationDrug Use in Dialysis
(Last Updated: 08/22/2018) Created by: Socco, Samantha Drug Use in Dialysis Drambarean, B. (2017). Drug Use in Dialysis. Lecture presented at PHAR 503 Lecture in UIC College of Pharmacy, Chicago. DIALYSIS
More informationIs Your Patient Receiving the Treatment You Prescribed?
Rx Tx Medical Directors Pre-Symposium Dallas, Texas September 22, 2011 Objectives Show the significance of staff s independent check of conductivity and ph Show significance of pressure alarm limits Show
More informationCRRT Fundamentals Pre- and Post- Test. AKI & CRRT Conference 2018
CRRT Fundamentals Pre- and Post- Test AKI & CRRT Conference 2018 Question 1 Which ONE of the following statements regarding solute clearance in CRRT is MOST correct? A. Convective and diffusive solute
More informationObjectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring
Peritoneal Dialysis Prescription and Adequacy Monitoring Christine B. Sethna, MD, EdM Division Director, Pediatric Nephrology Cohen Children s Medical Center Associate Professor Hofstra Northwell School
More informationFresenius Medical Care North America Corporate Headquarters Medical Department To: FMCNA Medical Directors 95 Hayden Ave
Fresenius Medical Care North America Corporate Headquarters Medical Department To: FMCNA Medical Directors 95 Hayden Ave Lexington, MA 02420-9192 From: J. Michael Lazarus, M.D. Date: July 5, 2005 Re: Bicarbonate
More informationUNDERSTANDING THE CRRT MACHINE
UNDERSTANDING THE CRRT MACHINE Helen Dickie Renal Sister Critical Care Unit Guy s and St.Thomas NHS Foundation Trust 18.10.14 RRT options - IHD vs CRRT (1) Intermittent HaemoDialysis e.g. 4hrs daily or
More informationIN THE NAME OF GOD Uremic toxins I. Small (< 500 D); water soluble Surrogate marker urea or sodium (ionic dialysance) Rapidly produced in intracellular fluid compartment Large variability in intra-patient
More informationHemodialysis is a life-sustaining procedure for the treatment of
The Dialysis Prescription and Urea Modeling Biff F. Palmer Hemodialysis is a life-sustaining procedure for the treatment of patients with end-stage renal disease. In acute renal failure the procedure provides
More informationCRRT Fundamentals Pre-Test. AKI & CRRT 2017 Practice Based Learning in CRRT
CRRT Fundamentals Pre-Test AKI & CRRT 2017 Practice Based Learning in CRRT Question 1 A 72-year-old man with HTN presents to the ED with slurred speech, headache and weakness after falling at home. He
More informationGeriatric Nutritional Risk Index, home hemodialysis outcomes 131
Subject Index Aksys PHD system 113 Anemia, home outcomes 111, 172, 173 Automated peritoneal dialysis dialysis comparison 17, 18 selection factors 18, 19 telemedicine system 19 21 Blood pressure -peritoneal
More informationSupplemental Quick Reference Guide
Supplemental Quick Reference Guide How to use this Supplemental Quick Reference Guide This guide provides a 5-step method for considering a variety of frequencies and treatment lengths, based on achieving
More informationMEDICAL EQUIPMENT II HEMODIALYSIS
MEDICAL EQUIPMENT II - 2012 HEMODIALYSIS Lecture 1 Prof. Yasser Mostafa Kadah Hemodialysis Machines Single-patient hemodialysis machines deliver a patient s dialysis prescription by controlling blood and
More informationANTIBIOTIC DOSE AND DOSE INTERVALS IN RRT and ECMO
ANTIBIOTIC DOSE AND DOSE INTERVALS IN RRT and ECMO Professor Jeffrey Lipman Department of Intensive Care Medicine Royal Brisbane Hospital University of Queensland NO CONFLICT OF INTERESTS Important concept
More informationHemodialysis Adequacy: A Complex and Evolving Paradigm. Balazs Szamosfalvi, MD Monday, 08/30/ :00-09:45
Hemodialysis Adequacy: A Complex and Evolving Paradigm Balazs Szamosfalvi, MD Monday, 08/30/2010 09:00-09:45 Adequacy 1943-1970 Fresenius The patient survived the dialysis session Uremia improved Volume
More informationMODALITIES of Renal Replacement Therapy in AKI
MODALITIES of Renal Replacement Therapy in AKI Jorge Cerdá, MD, MS, FACP, FASN Clinical Professor of Medicine Albany Medical College Albany, NY, USA cerdaj@mail.amc.edu In AKI, RRT is a multidimensional
More informationPhysiology of Blood Purification: Dialysis & Apheresis. Outline. Solute Removal Mechanisms in RRT
Physiology of Blood Purification: Dialysis & Apheresis Jordan M. Symons, MD University of Washington School of Medicine Seattle Children s Hospital Outline Physical principles of mass transfer Hemodialysis
More informationNephrology Dialysis Transplantation
Nephrol Dial Transplant (1996) 11 [Suppl 8]: 10-15 Nephrology Dialysis Transplantation Urea, sodium, and water changes in profiling dialysis H. Mann and S. Stiller ntroduction Control of osmolarity, as
More informationProceedings of the 36th World Small Animal Veterinary Congress WSAVA
www.ivis.org Proceedings of the 36th World Small Animal Veterinary Congress WSAVA Oct. 14-17, 2011 Jeju, Korea Next Congress: Reprinted in IVIS with the permission of WSAVA http://www.ivis.org 14(Fri)
More informationThere are no shortcuts to Dialysis
There are no shortcuts to Dialysis 1 Outcomes John Sweeny Wednesday, March 21 st, 2018 (3:10 pm 4:10 pm) 2 Quality in Hemodialysis Quality Health Care is the degree to which health services increases the
More informationKaren Mak R.N. (Team Leader) Renal Dialysis Centre Hong Kong Sanatorium & Hospital
Karen Mak R.N. (Team Leader) Renal Dialysis Centre Hong Kong Sanatorium & Hospital - Renal Transplantation - Peritoneal Dialysis - Extracorporeal Therapy Extracorporeal Therapy It is the procedure in
More informationModes of Extracorporeal Therapies For ESRD Patients
Modes of Extracorporeal Therapies For ESRD Patients Suhail, MD Extracorporeal Therapies: Dialytic Therapies Dialysis: Movement of molecules across a semipermeable membrane (Bi-directional) Movement of
More informationThe measurement of blood access flow rate (Qa; ml/min)
Hemodialysis Blood Access Flow Rates Can Be Estimated Accurately from On-Line Dialysate Urea Measurements and the Knowledge of Effective Dialyzer Urea Clearance Robert M. Lindsay,* Jan Sternby, Bo Olde,
More informationWhat is renal failure?
What is renal failure? The kidney is a very important organ, and cannot be restored to health once it fails. However, it is possible to avoid or retard the deterioration of its functionality if therapy
More information28-Feb-10 Reza Sabagh
DIALYSIS EQUIPMENTS (DIALYSIS MACHINE & R.O) Nursing Conference on Dialysis Tehran 1 The standard dialysis machines are designed for performing chronic and acute hemodialysis. They can be used in home
More informationEffect of increasing dialysate flow rate on diffusive mass transfer of urea, phosphate and β 2 -microglobulin during clinical haemodialysis
Nephrol Dial Transplant (2010) 25: 3990 3995 doi: 10.1093/ndt/gfq326 Advance Access publication 13 June 2010 Original Articles Effect of increasing dialysate flow rate on diffusive mass transfer of urea,
More informationStaff-Assisted Home Hemodialysis
Medical Coverage Policy Staff-Assisted Home Hemodialysis Table of Contents Coverage Policy... 1 Overview... 1 General Background... 2 Coding/Billing Information... 4 References... 4 Effective Date...11/15/2017
More informationManaging Acid Base and Electrolyte Disturbances with RRT
Managing Acid Base and Electrolyte Disturbances with RRT John R Prowle MA MSc MD MRCP FFICM Consultant in Intensive Care & Renal Medicine RRT for Regulation of Acid-base and Electrolyte Acid base load
More informationUAB CRRT Primer Ashita Tolwani, MD, MSc University of Alabama at Birmingham
UAB CRRT Primer 2018 Ashita Tolwani, MD, MSc University of Alabama at Birmingham 1 CRRT Primer Continuous Renal Replacement Therapy (CRRT) is a "catch all" term used for all the continuous modes of renal
More informationASN DIALYSIS ADVISORY GROUP ASN DIALYSIS CURRICULUM
ASN DIALYSIS ADVISORY GROUP ASN DIALYSIS CURRICULUM Medical Management of Home Hemodialysis Patients Brent W. Miller, MD Professor of Medicine Washington University School of Medicine Saint Louis, Missouri
More informationKidney Failure. Haemodialysis
Kidneys & Kidney Failure 2 Haemodialysis This booklet will help you to know the process of Haemodialysis in detail. It will also tell you about the disposables of Haemodialysis. In the end the advantages
More informationOperation-Fluids-Electrolytes-Acid Base COMPLICATIONS OF DIALYSIS 2
Operation-Fluids-Electrolytes-Acid Base COMPLICATIONS OF DIALYSIS 2 Maureen Craig, RN, MSN, CNN University of California Davis Medical Center Sacramento, California macraig@ucdavis.edu Hospital Details
More informationDialysis Dose Prescription and Delivery. William Clark, M.D. Claudio Ronco, M.D. Rolando Claure-Del Granado, M.D. CRRT Conference February 15, 2012
Dialysis Dose Prescription and Delivery William Clark, M.D. Claudio Ronco, M.D. Rolando Claure-Del Granado, M.D. CRRT Conference February 15, 2012 Dose in RRT: Key concepts Dose definition Quantifying
More informationCRRT Fundamentals Pre- and Post- Test Answers. AKI & CRRT 2017 Practice Based Learning in CRRT
CRRT Fundamentals Pre- and Post- Test Answers AKI & CRRT 2017 Practice Based Learning in CRRT Question 1 A 72-year-old man with HTN presents to the ED with slurred speech, headache and weakness after falling
More informationDialysis technologies
Moscow Institute of Electronic Technology Dialysis technologies Kidneys Remove toxic by-products of the metabolism and molecules smaller than 69000Da Regulate body fluid composition and volume Provide
More informationAchieving Equilibrium in ESRD Patients
Achieving Equilibrium in ESRD Patients -Marc Richards MD -South Florida Kidney Disease and HTN Specialists -Chief of Medicine, BRRH -BRRH Grand Rounds: April 18 th, 2017 Outline Dialysis prescription Adequacy
More informationContinuous Renal Replacement Therapy. Gregory M. Susla, Pharm.D., F.C.C.M. Associate Director, Medical Information MedImmune, LLC Gaithersburg, MD
Continuous Renal Replacement Therapy Gregory M. Susla, Pharm.D., F.C.C.M. Associate Director, Medical Information MedImmune, LLC Gaithersburg, MD 1 Definition of Terms SCUF - Slow Continuous Ultrafiltration
More informationContinuous Renal Replacement Therapy
Continuous Renal Replacement Therapy Gregory M. Susla, Pharm.D., F.C.C.M. Associate Director, Medical Information MedImmune, LLC Gaithersburg, MD Definition of Terms SCUF - Slow Continuous Ultrafiltration
More informationThe goal of dialysis for patients with chronic renal failure is to
Dialysate Composition in Hemodialysis and Peritoneal Dialysis Biff F. Palmer The goal of dialysis for patients with chronic renal failure is to restore the composition of the body s fluid environment toward
More informationEnhancement of convective transport by internal filtration in a modified experimental hemodialyzer Technical Note
Kidney International, Vol. 54 (1998), pp. 979 985 Enhancement of convective transport by internal filtration in a modified experimental hemodialyzer Technical Note CLAUDIO RONCO, GIANCARLO ORLANDINI, ALESSANDRA
More informationContinuous renal replacement therapy. David Connor
Continuous renal replacement therapy David Connor Overview Classification of AKI Indications Principles Types of CRRT Controversies RIFL criteria Stage GFR Criteria Urine Output Criteria Risk Baseline
More informationProlonged Dialysis: 24-hr SLED Is It CRRT? Balazs Szamosfalvi, MD
Prolonged Dialysis: 24-hr SLED Is It CRRT? Balazs Szamosfalvi, MD Medical Director, In-patient Dialysis and CRRT Henry Ford Hospital, Detroit, Michigan, USA Presenter Disclosure Information I will discuss
More informationRenal Physiology Intro to CRRT Concepts. Catherine Jones September 2017
Renal Physiology Intro to CRRT Concepts Catherine Jones September 2017 Learning Outcomes To revise anatomy & physiology of kidney in health: To understand basic principles of continuous renal replacement
More informationPhil. J. Internal Medicine, 47: 19-23, Jan.-Feb., 2009
Original Articles Assessment of Hemodialysis Adequacy 19 Phil. J. Internal Medicine, 47: 19-23, Jan.-Feb., 2009 ASSESSMENT OF HEMODIALYSIS ADEQUACY: IONIC DIALYSANCE IN COMPARISON TO STANDARD METHOD KT/V-MAKATI
More informationExplorations fonctionnelles des abords vasculaires pour hémodialyse
Explorations fonctionnelles des abords vasculaires pour hémodialyse Frank Le Roy Nephrology Department Actualités Néphrologiques Jean Hamburger Necker, 27 avril 2015 1966 Brescia, Cimino, Appel, Hurwich.
More informationCRRT for the Experience User 1. Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference March, 2018
CRRT for the Experience User 1 Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference March, 2018 Disclosures I have no actual or potential conflict of interest
More informationSystem Dynamics Highlights the Effect of Maintenance on Hemodialysis Performance
System Dynamics Highlights the Effect of Maintenance on Hemodialysis Performance Ahmad Taher Azar 1 Assistant Instructor, Systems and Biomedical Engineering Department Higher Technological Institute, Tenth
More informationActive UMMC Protocols
UMMC CRRT 2018 Active UMMC Protocols 1. Standard CRRT Protocol PrismaFlex & NxStage CVVH with Fixed Ratio Regional Citrate Anticoagulation 2. No Anticoagulation Protocol PrismaFlex & NxStage CVVH with
More informationHEMODIALFILTRATION LITERATURE REVIEW AND PRACTICE CONSIDERATIONS 1.0 PRACTICE CONSIDERATIONS 2.0 CURRENT LITERATURE REVIEW
HEMODIALFILTRATION LITERATURE REVIEW AND PRACTICE CONSIDERATIONS This document was prepared at the request of the BC Hemodialysis Committee to provide a brief overview of the literature and to identify
More informationPrincipal Equations of Dialysis. John A. Sweeny
Principal Equations of Dialysis John A. Sweeny john@sweenyfamily.net 1 An Equation is Math: A statement that each of two statements are equal to each other. Y 2 = 3x 3 + 2x + 7 Chemistry: A symbolic expression
More informationImplantable Dialysis Device for Treatment of Renal Failure
Implantable Dialysis Device for Treatment of Renal Failure Outline Kidney function Renal Failure Dialysis overview Device Proposal Fabrication Methods Biocompatibility Conclusion Function of the kidneys
More informationRenal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology
Renal Disease and PK/PD Anjay Rastogi MD PhD Division of Nephrology Drugs and Kidneys Kidney is one of the major organ of drug elimination from the human body Renal disease and dialysis alters the pharmacokinetics
More informationDiacap. Constant performance resulting in high quality dialysis. Avitum
Diacap Constant performance resulting in high quality dialysis Avitum B. Braun Avitum. Always with Passion. B. Braun is a leading international company in the healthcare market. With a long tradition stretching
More informationIN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006
IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006 PATIENT IDENTIFICATION [Before completing please read instructions at the bottom of this page and on pages 5 and 6] MAKE
More informationHemodialysis: Techniques and Prescription
CORE CURRICULUM IN NEPHROLOGY Hemodialysis: Techniques and Prescription T. Alp Ikizler, MD, and Gerald Schulman, MD INTRODUCTION HEMODIALYSIS (HD) is the routine renal replacement therapy for more than
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Blood urea sampling methods GUIDELINES
Date written: November 2004 Final submission: July 2005 Blood urea sampling methods GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions are
More informationMeasuring Sodium in dialysis patients. UCL Center for Nephrology
Measuring Sodium in dialysis patients UCL Center for Nephrology sodium Na-heparin sulphate Na-dermatan sulphate Na-chondroitin sulphate endothelium Na-heparin sulphate Na-Sulfate plasma protein Na-Citrate
More informationDialysis Adequacy (HD) Guidelines
Dialysis Adequacy (HD) Guidelines Peter Kerr, Convenor (Monash, Victoria) Vlado Perkovic (Camperdown, New South Wales) Jim Petrie (Woolloongabba, Queensland) John Agar (Geelong, Victoria) Alex Disney (Woodville,
More informationCSI (Clinical Scenario Investigation): Hyperkalemia
CSI (Clinical Scenario Investigation): Hyperkalemia Alison Thomas, RN(EC), MN, CNeph(C) Ann Jones, RN(EC), MSN, CNeph(C) Joyce Hunter, RN, Vascular Access Co-ordinator Simcoe Muskoka Regional Kidney Care
More informationHaemodialysis. Online Clearance Monitoring Assuring the Desired Dose of Dialysis
Haemodialysis Online Clearance Monitoring Assuring the Desired Dose of Dialysis Contents 1. Foreword 2. Dialysis dose 2.1 Standard methods of determination of the dialysis dose 2.1.1 Urea Reduction Ratio
More informationThe kidneys maintain the body s homeostasis by
Rationale for Daily Dialysis Umberto Buoncristiani, Riccardo Fagugli, Giuseppe Quintaliani, Hrissanti Kulurianu Nephrology-Dialysis Unit, Ospedale Regionale, Perugia, Italy. The kidneys maintain the body
More informationECMO & Renal Failure Epidemeology Renal failure & effect on out come
ECMO Induced Renal Issues Transient renal dysfunction Improvement in renal function ECMO & Renal Failure Epidemeology Renal failure & effect on out come With or Without RRT Renal replacement Therapy Utilizes
More informationRenal Replacement Therapy in ICU. Dr. Sunil Sharma Senior Resident Dept of Pulmonary Medicine
Renal Replacement Therapy in ICU Dr. Sunil Sharma Senior Resident Dept of Pulmonary Medicine Introduction Need for RRT in patients with ARF is a common & increasing problem in ICUs Leading cause of ARF
More informationPatients and Machines. NANT Annual National Symposium Wednesday March 9 th, 2011
Patients and Machines John A Sweeny John A. Sweeny NANT Annual National Symposium Wednesday March 9 th, 2011 Caroline Helm Caroline Helm was the first homepatient in the United States. She was a patient
More information- SLED Sustained Low-Efficiency Dialysis
Continuous Renal Replacement Therapy Gregory M. Susla, Pharm.D., F.C.C.M. Associate Director, Medical Information MedImmune, LLC Gaithersburg, MD 1 Definition of Terms - SCUF - Slow Continuous Ultrafiltration
More informationOn-site production of a dialysis bath from dry salts. Results of solute concentration control by routine clinical chemistry
Clin Kidney J (2012) 5: 207 211 doi: 10.1093/ckj/sfs043 Original Article On-site production of a dialysis bath from dry salts. Results of solute concentration control by routine clinical chemistry Joachim
More informationDialysate Composition: Accuracy of the Prescription
Rx Tx Dialysate Composition: Accuracy of the Prescription NANT 2016 Annual Symposium March 23, 2016 Las Vegas, NV Joe Johnston Sr. Vice Pres. Biomedical Services Fresenius Medical Care The Starting Point
More informationGambro Renal Products Technical Assistance Services
Gambro Renal Products Technical Assistance Services http://tech.usa-gambro.com 800/525-2623 303/232-6800 Technical Update PH,TR,11060 12/2008 TROUBLESHOOTING Equipment Type: Phoenix Dialysis System Subject:
More informationEXCRETION QUESTIONS. Use the following information to answer the next two questions.
EXCRETION QUESTIONS Use the following information to answer the next two questions. 1. Filtration occurs at the area labeled A. V B. X C. Y D. Z 2. The antidiuretic hormone (vasopressin) acts on the area
More informationegfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31
Update on Renal Therapeutics Caroline Ashley Lead Pharmacist Renal Services UCL Centre for Nephrology, Royal Free Hospital, London Kongress für Arzneimittelinformation January 2011 What are we going to
More informationOld Dialysis Technical Guy
John A. Sweeny Old Dialysis Technical Guy 1 WHAT IS UREA? A compound formed in the liver by the process known as the urea cycle. Gram Molecular Weight = 60 Daltons Carbon - Oxygen - Nitrogen - Hydrogen
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our
More informationSolute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters
Nephrol Dial Transplant (2003) 18: 961 966 DOI: 10.1093/ndt/gfg055 Original Article Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100
More informationHaemodialysis. The AutoFlow Function for the 5008 Therapy System Optimising the Dialysis Fluid Flow Rate
Haemodialysis The AutoFlow Function for the 5008 Therapy System Optimising the Dialysis Fluid Flow Rate 2 The Dialysis Fluid Flow Rate In current dialysis practice, a dialysis fluid flow rate of either
More informationHemodiafiltration in Europe : Trends, Practices, Outcomes & Perspectives
Hemodiafiltration in Europe : Trends, Practices, Outcomes & Perspectives Prof. Bernard Canaud Nephrology, Dialysis and Intensive Care Lapeyronie Hospital CHRU Montpellier - France Opening remarks and special
More informationRecent advances in CRRT
Recent advances in CRRT JAE IL SHIN, M.D., Ph.D. Department of Pediatrics, Severance Children s Hospital, Yonsei University College of Medicine, Seoul, Korea Pediatric AKI epidemiology and demographics
More informationDialysis in the Acute Setting
Dialysis in the Acute Setting medicine2.missouri.edu/jahm/dialysis-in-the-acute-setting/ October 8, 2015 Kunal Malhotra, MD Division of Nephrology, Department of Medicine, University of Missouri School
More informationCRRT. Sustained low efficiency daily dialysis, SLEDD. Sustained low efficiency daily diafiltration, SLEDD-f. inflammatory cytokine IL-1 IL-6 TNF-
RRT, renal replacement therapy IHDCRRT CRRT 24 CRRT Sustained low efficiency daily dialysis, SLEDD 6 ~ 12 300 Sustained low efficiency daily diafiltration, SLEDD-f inflammatory cytokine IL-1 IL-6 TNF-
More informationNew method of blood purification (Recycle Filtration System)
Tokai J Exp Clin Med., Vol. 33, No. 3, pp. 124-129, 2008 New method of blood purification (Recycle Filtration System) Hajime SUZUKI 1), Miho HIDA 1), Makoto KITAMURA 1), Shin-ichi TANAKA 2), Takayo MIYAKOGAWA
More information2019 Home Hemodialysis Standing Orders
2019 Home Hemodialysis Standing Orders 1. Nutrition Standards of Care: A. Follow P&P Nutrition Standards of Care 2. Laboratory Tests: A. Drawn On Admission: 1. Renal Function Panel (BMP, PO 4 and Albumin)
More informationHDx THERAPY. Enabled by. Making possible personal.
HDx THERAPY Enabled by Making possible personal. THE NEXT HORIZON IN DIALYSIS IS CLOSER THAN YOU THINK PHOSPHATE UREA HDx BY THERANOVA EXPANDS YOUR RENAL POSSIBILITIES The new HDx therapy (expanded HD)
More informationCITRATE DIALYSIS FLUID
CITRATE DIALYSIS FLUID Making possible personal. A CITRATE CONTAINING DIALYSIS FLUID FREE OF ACETATE The Gambro SoftPac concentrate is a citrate-containing, acetate-free concentrate developed by Gambro
More informationNurse-Pharmacist Collaboration in the Delivery of Continuous Renal Replacement Therapy
Cedarville University DigitalCommons@Cedarville Pharmacy Faculty Presentations School of Pharmacy 2-23-2012 Nurse-Pharmacist Collaboration in the Delivery of Continuous Renal Replacement Therapy Jeb Ballentine
More informationNephros On-line Mid-Dilution Hemodiafiltration System
_PO Nephros On-line Mid-Dilution Hemodiafiltration System Clinicians Overview with Safety and Efficacy Summary Note: Federal (USA) law restricts these devices to sale by or on the order of a physician.
More informationINSPIRED BY LIFE B. BRAUN DIALYZERS
INSPIRED BY LIFE B. BRAUN DIALYZERS OUR COMMITMENT. FOR LIFE. The Diacap Pro and xevonta dialyzers offer a broad range of high-quality dialyzers for individual treatment needs. It began in 1839, inspired
More informationControl of hyperphosphatemia is a major goal in patients
ORIGINAL ARTICLES Phosphorus Clearance Using Two Hemodialyzers Placed in Parallel Mitchell H. Rosner, 1,2 Allen Helmandollar, 1 Ryan Evans, 1 Emaad Abdel-Rahman 1 Division of Nephrology, 1 University of
More informationWearable Artificial Kidney Juan Malvar Biomedical Engineering University of Rhode Island November 10, 2015
Wearable Artificial Kidney Juan Malvar Biomedical Engineering University of Rhode Island November 10, 2015 CKD AND ESKD CKD (Chronic Kidney Disease)-presence of kidney damage ESKD (End-Stage Kidney Disease)-
More informationHomework Assignment # 2 due Friday, September 1 st
Homework Assignment # 2 due Friday, September 1 st 1. The electrostatic charge generation for hydrated lime powder during pneumatic transport can be described by the following relationship: q/m= Aw b u
More informationOsmoregulation and Osmotic Balance
OpenStax-CNX module: m44808 1 Osmoregulation and Osmotic Balance OpenStax College This work is produced by OpenStax-CNX and licensed under the Creative Commons Attribution License 3.0 By the end of this
More informationCrit-Line Monitor. Frequently Asked Questions
Crit-Line Monitor Frequently Asked Questions Crit-Line Monitor Frequently Asked Questions 1 What is the indication for use of the Crit-Line monitor? The Crit-Line Monitor III is used to non-invasively
More informationKidneys and Homeostasis
16 The Urinary System The Urinary System OUTLINE: Eliminating Waste Components of the Urinary System Kidneys and Homeostasis Urination Urinary Tract Infections Eliminating Waste Excretion Elimination of
More informationTechnical Considerations for Renal Replacement Therapy in Children
Technical Considerations for Renal Replacement Therapy in Children Timothy E. Bunchman, MD,* Patrick D. Brophy, MD, and Stuart L. Goldstein, MD Summary: Provision of renal replacement therapy to the critically
More informationEnd-Stage Renal Disease. Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology
End-Stage Renal Disease Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology ESRD : Life with renal replacement therapy CASE: 18 month old male with HUS develops ESRD PD complicated
More informationGUIDELINE FOR HAEMODIALYSIS PRESCRIPTION FOR NEW PATIENTS COMMENCING HAEMODIALYSIS
GUIDELINE FOR HAEMODIALYSIS PRESCRIPTION FOR NEW PATIENTS COMMENCING HAEMODIALYSIS RRCV CMG Nephrology Service 1. Introduction A first acute or chronic haemodialysis session may induce disequilibrium syndrome
More informationUnderstanding Kt/V and Volume Control
Understanding Kt/V and Volume Control Its practical use to determine dialysis and improve outcomes Caroline Williams RD May 23, 2017 Volume Control in Dialysis Patients Pathogenesis In the 1960s and early
More informationCalcium Management for Patients Receiving Extended Duration Hemodialysis
Calcium Management for Patients Receiving Extended Duration Hemodialysis Created November 2017; Updated March 2018 Approved by the BCPRA Home Hemodialysis Committee Table of Contents 1.0 Practice Standard...1
More informationLife Inside a Single Hollow Fiber
Life Inside a Single Hollow Fiber John Sweeny Thursday, March 22 nd, 2018 (4:00 pm 5:30 pm) 1 Seeing The Dialysis Process As human beings, we are limited in our ability to observe the processes occurring
More informationMembrane Function. How does the cell membrane control movement of materials? Type 1 Ions Type 2 Molecules Type 3 Molecules Type 4 Molecules H O H
Why? Membrane Function ow does the cell membrane control movement of materials? The membrane is critical to the maintenance of homeostasis in living organisms. The cell membrane separates the cell from
More informationI. FILL IN THE BLANKS
1 BHARAT SEVAK SAMAJ NATIONAL DEVELOPMENT AGENCY, PROMOTED BY GOVERNMENT OF INDIA CENTRAL BOARD OF EXAMINATIONS BSS NATIONAL VOCATIONAL EDUCATION MISSION AHE025-BSS DIPLOMA IN DIALYSIS TECHNOLOGY TWO YEARS
More information